Many
pediatric stem cell transplant and oncology outpatients have central lines to deliver chemotherapy and other medications.
Steven P. Margossian, MD, PhD Senior Physician, Stem Cell Transplant Center Dr. Margossian is a member of one of the largest
pediatric stem cell transplant centers in the country and excels at helping children and families adjust during diagnosis and treatment.
Not exact matches
Abatacept, when added to the standard drug regimen used to prevent GvHD, reduced the occurrence of acute, grade III - IV GvHD from 32 to 3 percent in
pediatric and adult patients who underwent mismatched unrelated donor
stem cell transplants to treat advanced cancer and other blood disorders.
Because a large portion of
pediatric oncology and
stem cell transplant patients» care occurs in ambulatory settings, the consortium is now focusing on understanding and reducing CLABSIs that originate in the home, between outpatient clinic visits.
Strengthen physical assessment skills essential for the care of
pediatric and adolescent oncology, hematology and
stem cell transplant patients
Experts in
pediatric oncology,
pediatric surgery,
cell and gene therapy including
stem cell transplant, radiation oncology,
pediatric anesthesia, pharmacology, social work, child life and the full complement of
pediatric subspecialty services put a strong focus on family - centered care and emotional support for both the child and the family.